The goal of this observational study is to improve early detection, characterization, and understanding of heart failure with preserved ejection fraction (HFpEF) in adults at risk of or diagnosed with HFpEF, including men and women across Danish regions.
The main questions to answer are:
Can systematic cardiovascular screening and deep phenotyping improve early identification and classification of HFpEF?
Which clinical, imaging, biomarker, and metabolic characteristics define subtypes (phenotypes) of HFpEF and predict disease progression and outcomes?
Researchers will compare participants with HFpEF, participants at risk of HFpEF, and relevant control groups to see if differences in biomarkers, imaging findings, and clinical characteristics can identify early disease stages and distinct HFpEF phenotypes.
Participants identified with HFpEF will:
* Undergo detailed cardiovascular examinations (e.g., echocardiography, CT and other imaging examinations, RHC, CPET)
* Provide blood and tissue samples for biomarker and metabolic analyses
* Complete clinical assessments and questionnaires
* Have relevant health data collected from national health registries
* Attend follow-up assessments to monitor disease progression